Combining immunomodulators and antivirals for COVID-19
نویسندگان
چکیده
منابع مشابه
COVID-19: combining antiviral and anti-inflammatory treatments
The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs. In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...
متن کاملCOVID-19 and dermatologists
Since the beginning of COVID-19 pandemic on December 2019, challenges on economic, political, social, hygiene- therapeutic and life style have emerged in many countries. Many researches are investigating on virus characteristics and its behavior and also preventive and therapeutic measures. Despite the virus not being dermatotropic, several skin manifestations have been observed. In this review...
متن کاملChemoprophylatic. Ayurvedic, Homeopathic and Unani approaches for COVID-19 prophylaxis
There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need ...
متن کاملMedical strategies for Disease Covid-19
Following the outbreak of Covid-19, many related studies were published rapidly around the world. In this study, we examined published or in-publication studies over the strategies to deal with Covid-19. To this end, 16 published scientific papers were investigated using content analysis and meta-analysis. As a result, 16 medical strategies and 3 macro-management strategies were extracted. Fina...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Microbe
سال: 2021
ISSN: 2666-5247
DOI: 10.1016/s2666-5247(21)00114-2